U.S. flag

An official website of the United States government

NM_001267550.2(TTN):c.70492G>A (p.Gly23498Ser) AND not specified

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jun 19, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000040556.7

Allele description [Variation Report for NM_001267550.2(TTN):c.70492G>A (p.Gly23498Ser)]

NM_001267550.2(TTN):c.70492G>A (p.Gly23498Ser)

Genes:
LOC126806422:BRD4-independent group 4 enhancer GRCh37_chr2:179440205-179441404 [Gene]
TTN-AS1:TTN antisense RNA 1 [Gene - HGNC]
TTN:titin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q31.2
Genomic location:
Preferred name:
NM_001267550.2(TTN):c.70492G>A (p.Gly23498Ser)
Other names:
p.G20930S:GGC>AGC
HGVS:
  • NC_000002.12:g.178575640C>T
  • NG_011618.3:g.260163G>A
  • NG_051363.1:g.57814C>T
  • NM_001256850.1:c.65569G>A
  • NM_001267550.2:c.70492G>AMANE SELECT
  • NM_003319.4:c.43297G>A
  • NM_133378.4:c.62788G>A
  • NM_133432.3:c.43672G>A
  • NM_133437.4:c.43873G>A
  • NP_001243779.1:p.Gly21857Ser
  • NP_001254479.2:p.Gly23498Ser
  • NP_003310.4:p.Gly14433Ser
  • NP_596869.4:p.Gly20930Ser
  • NP_597676.3:p.Gly14558Ser
  • NP_597681.4:p.Gly14625Ser
  • LRG_391:g.260163G>A
  • NC_000002.11:g.179440367C>T
  • NM_003319.4:c.43297G>A
  • c.62788G>A
Protein change:
G14433S
Links:
dbSNP: rs370771532
NCBI 1000 Genomes Browser:
rs370771532
Molecular consequence:
  • NM_001256850.1:c.65569G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001267550.2:c.70492G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003319.4:c.43297G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133378.4:c.62788G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133432.3:c.43672G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133437.4:c.43873G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
2

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000064247Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Uncertain significance
(Dec 3, 2013)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004020325Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Jun 19, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided22not providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

A 14-year-old in heart failure with multiple cardiomyopathy variants illustrates a role for signal-to-noise analysis in gene test re-interpretation.

Connell PS, Jeewa A, Kearney DL, Tunuguntla H, Denfield SW, Allen HD, Landstrom AP.

Clin Case Rep. 2019 Jan;7(1):211-217. doi: 10.1002/ccr3.1920.

PubMed [citation]
PMID:
30656044
PMCID:
PMC6332775

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000064247.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testing PubMed (1)

Description

The Gly20930Ser variant in TTN has now been identified by our laboratory in 1 As hkenazi Jewish adult with HCM and 1 Caucasian adult with DCM. This variant has a lso been identified in 1/8264 European American and 1/3864 African American chro mosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS) . Computational analyses (biochemical amino acid properties, conservation, Align GVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impac t to the protein. Additional information is needed to fully assess the clinical significance of the Gly20930Ser variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided2not provided2not provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004020325.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: TTN c.62788G>A (p.Gly20930Ser) results in a non-conservative amino acid change located in the A-band region of the encoded protein sequence. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00023 in 248498 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in TTN causing Cardiomyopathy (0.00023 vs 0.00039), allowing no conclusion about variant significance. c.62788G>A has been reported in the literature in an individual affected with Cardiomyopathy without evidence for causality (Connell_2019). This report does not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 30656044). Six submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as either VUS (n=4) or benign (n=1)/likely benign (n=1). Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 13, 2025